Harvard University — Boston, Massachusetts

Harvard University is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Harvard University has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3.

Sponsors: University of Florida, Duke University, Kura Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harvard University?

Harvard University has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harvard University conducted?

Harvard University has 9 clinical trials on record, with 1 currently active. Their work covers Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2, Spinocerebellar Ataxia Type 3.

Is Harvard University accredited by Crixeo Health?

Yes — Harvard University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Harvard University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.